NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/07/2026
Voltar para busca
Dado oficial do USPTO
CLEARSEE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
21/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
15/10/2025
Data de registro
21/07/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/07/2026
Última transação
21/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
25
Localização do titular
CH
Examinador
RIBAUDO, MICHELLE RACHEL
Unidade examinadora
N80
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
NOVARTIS AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Classe 10
Medical apparatus for treating respiratory conditionsdiabetescardiovascular and metabolic disordersdiseases of the nervous systeminflammatory disorders and for use in dermatology
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
21/07/2026
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
28/06/2026
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/06/2026
CHPB
POST PUBLICATION AMENDMENT - ENTERED
24/05/2026
APET
ASSIGNED TO PETITION STAFF
22/05/2026
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
14/05/2026
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
01/04/2026
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
19/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/02/2026
PUBO
PUBLISHED FOR OPPOSITION
17/02/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/01/2026
DOCK
ASSIGNED TO EXAMINER
23/01/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
13/01/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/01/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/01/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/01/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
13/01/2026
MAFR
APPLICATION FILING RECEIPT MAILED
12/01/2026
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2026
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/01/2026
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/12/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CLEARSEE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.